Latest / Stock Movers / Amer Sports Rises, Amylyx Jumps, and Klarna Plunges as FY Guidance Misses
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios podcasts, radio news, The Stock Movers podcast,
- 0:10Speaker 1: your roundup of companies making moves in the stock market,
- 0:14Speaker 1: harnessing the power of Bloomberg Data. Let's take a look
- 0:18Speaker 1: at some of the stocks on the move today.
- 0:19Speaker 2: We can do that with the Carmen and Raniky, Deputy
- 0:20Speaker 2: team leader for the US Equities Carman, what are you
- 0:22Speaker 2: looking at? Yeah, so the first one I'm looking at
- 0:24Speaker 2: this morning is actually up today amer Sports ticker as
- 0:28Speaker 2: it's up about three point two percent. This is the
- 0:31Speaker 2: most in about three weeks. So I feel like you
- 0:34Speaker 2: see this story if you just look at people's footwear
- 0:36Speaker 2: on the streets of New York. So, this company makes
- 0:39Speaker 2: Wilson tennis rackets and also is responsible for Solomon and
- 0:42Speaker 2: Arctic's brand.
- 0:43Speaker 1: I love the Solomon ski stuff.
- 0:45Speaker 2: Oh my god, thanks you. Socially, Oh you do the
- 0:47Speaker 2: ski stuff too. I have the trailer runners. Oh okay, okay,
- 0:50Speaker 2: very into those. But anyway, so the company boosted its
- 0:52Speaker 2: guides for the second time this year, and it's driven
- 0:55Speaker 2: particularly by growth at Solomon, Arcs and Arctics brands. Very
- 1:00Speaker 2: good lifting lifting things for the company there.
- 1:02Speaker 1: I'm not sure I think the name am or am
- 1:06Speaker 1: I'm not sure, mayor I'm mayor so.
- 1:07Speaker 2: How I think?
- 1:08Speaker 1: So okay, you'll go with it.
- 1:10Speaker 2: What else you got yip? Next time I'm looking at
- 1:12Speaker 2: is I mean another tough name? Amelks Pharmaceuticals ticker am ALX.
- 1:17Speaker 2: This stock is up forty seven percent right now. This
- 1:20Speaker 2: is the most intra day since September of twenty twenty two.
- 1:25Speaker 2: So this is jumping like this after the drug developer
- 1:28Speaker 2: said that a late stage trial of an experimental drug,
- 1:32Speaker 2: which is for patients who experienced dangerously low blood sugar
- 1:36Speaker 2: levels following bariatric surgery, met its primary endpoint. Treatment. Analyst
- 1:41Speaker 2: at Stifel said these results were a best case scenario
- 1:44Speaker 2: and City also come out with a note today saying
- 1:48Speaker 2: that this you know the efficacy, efficacy, consistency and safety.
- 1:53Speaker 2: Here is a benefit. Very good.
- 1:55Speaker 1: Okay.
- 1:56Speaker 2: One more Klarna Yep, some some red on the screen
- 1:59Speaker 2: here today. So shares of Klarna ticker KLA are down
- 2:03Speaker 2: a nineteen percent. This is the worst since February. The
- 2:07Speaker 2: company reported full year revenue and gross merchandise value that
- 2:11Speaker 2: guidance that missed expectations, and active consumers for the second
- 2:16Speaker 2: quarter also missed expectations. Here. This stock is down more
- 2:20Speaker 2: than sixty percent since it ipoed just over a year ago.
- 2:25Speaker 1: The Stock Movers podcast from Bloomberg Radio. Check back with
- 2:29Speaker 1: us throughout the day for the latest roundup of companies
- 2:32Speaker 1: making news on Wall Street and for the latest market
- 2:35Speaker 1: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
- 2:39Speaker 1: Bloomberg dot com, and on Applecarplay and Android Auto with
- 2:42Speaker 1: the Bloomberg Business app.